Bio Behavioral Health Joins PhaseWell Research to Expand Access to Neuropsychiatric Clinical Trials
PhaseWell Research (“PhaseWell”), a national clinical research site company, today announced a new partnership with Bio Behavioral Health (“BBH”), a leading central nervous system (CNS) research site focused in neurologic and psychiatric disorders. The partnership reflects PhaseWell’s continued commitment to connecting communities to clinical trials, bringing hope today and shaping tomorrow’s medicine.
